Amniotic fluid alpha‐fetoprotein subfractions in fetal Trisomy 21 affected pregnancies
- 1 April 1988
- journal article
- research article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 95 (4) , 327-329
- https://doi.org/10.1111/j.1471-0528.1988.tb06600.x
Abstract
Summary. The percentage contribution to the total AFP concentration in amniotic fluid from the yolk sac derived AFP was measured at 15–17 weeks gestation in 15 pregnancies affected by fetal Trisomy 21 and compared with that in 75 pregnancies with a normal outcome. The yolk sac form of AFP was reduced in parallel to the total AFP and differentiation of the subtraction from the yolk sac would offer no increase in diagnostic efficiency.This publication has 10 references indexed in Scilit:
- AMNIOTIC FLUID ALPHA-FETOPROTEIN LEVELS IN DOWN SYNDROMEThe Lancet, 1986
- Serum cytidine deaminase assay—some pitfallsBJOG: An International Journal of Obstetrics and Gynaecology, 1986
- Low alpha-fetoprotein and serum albumin levels in Morbus Down may point to a common regulatory mechanismHuman Genetics, 1985
- AMNIOTIC FLUID AFP LEVELS AND DOWN SYNDROMEThe Lancet, 1985
- An association between low maternal serum α-fetoprotein and fetal chromosomal abnormalitiesAmerican Journal of Obstetrics and Gynecology, 1984
- Concanavalin A binding of alpha-fetoprotein in amniotic fluid as an aid in the diagnosis of neural tube defects.Clinical Chemistry, 1981
- Reactivity of amniotic fluid alpha-fetoprotein with concanavalin A in relation to gestational age: clinical implications.Clinical Chemistry, 1980
- Determination of subfractions of amniotic fluid alpha-fetoprotein in diagnosing spina bifida and congenital nephrosis.BMJ, 1979